Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

710 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease.
Kumagai E, Mano Y, Yoshio S, Shoji H, Sugiyama M, Korenaga M, Ishida T, Arai T, Itokawa N, Atsukawa M, Hyogo H, Chayama K, Ohashi T, Ito K, Yoneda M, Kawaguchi T, Torimura T, Nozaki Y, Watanabe S, Mizokami M, Kanto T. Kumagai E, et al. Among authors: mizokami m. Sci Rep. 2016 Oct 14;6:35282. doi: 10.1038/srep35282. Sci Rep. 2016. PMID: 27739482 Free PMC article.
Dynamic epidemiology of acute viral hepatitis in Japan.
Yano K, Tamada Y, Yatsuhashi H, Komori A, Abiru S, Ito K, Masaki N, Mizokami M, Ishibashi H; Japan National Hospital Acute Hepatitis Study Group. Yano K, et al. Among authors: mizokami m. Intervirology. 2010;53(1):70-5. doi: 10.1159/000252788. Epub 2010 Jan 5. Intervirology. 2010. PMID: 20068345
ITPA gene variant protects against anemia induced by pegylated interferon-α and ribavirin therapy for Japanese patients with chronic hepatitis C.
Sakamoto N, Tanaka Y, Nakagawa M, Yatsuhashi H, Nishiguchi S, Enomoto N, Azuma S, Nishimura-Sakurai Y, Kakinuma S, Nishida N, Tokunaga K, Honda M, Ito K, Mizokami M, Watanabe M. Sakamoto N, et al. Among authors: mizokami m. Hepatol Res. 2010 Nov;40(11):1063-71. doi: 10.1111/j.1872-034X.2010.00741.x. Hepatol Res. 2010. PMID: 20977565
Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors.
Kurosaki M, Tanaka Y, Nishida N, Sakamoto N, Enomoto N, Honda M, Sugiyama M, Matsuura K, Sugauchi F, Asahina Y, Nakagawa M, Watanabe M, Sakamoto M, Maekawa S, Sakai A, Kaneko S, Ito K, Masaki N, Tokunaga K, Izumi N, Mizokami M. Kurosaki M, et al. Among authors: mizokami m. J Hepatol. 2011 Mar;54(3):439-48. doi: 10.1016/j.jhep.2010.07.037. Epub 2010 Sep 19. J Hepatol. 2011. PMID: 21129805
The rs8099917 polymorphism, when determined by a suitable genotyping method, is a better predictor for response to pegylated alpha interferon/ribavirin therapy in Japanese patients than other single nucleotide polymorphisms associated with interleukin-28B.
Ito K, Higami K, Masaki N, Sugiyama M, Mukaide M, Saito H, Aoki Y, Sato Y, Imamura M, Murata K, Nomura H, Hige S, Adachi H, Hino K, Yatsuhashi H, Orito E, Kani S, Tanaka Y, Mizokami M. Ito K, et al. Among authors: mizokami m. J Clin Microbiol. 2011 May;49(5):1853-60. doi: 10.1128/JCM.02139-10. Epub 2011 Mar 9. J Clin Microbiol. 2011. PMID: 21389156 Free PMC article.
710 results